Drugs / PfPEBS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01605786 | May 2012 → May 2013 | malaria | Vac4All | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PfPEBS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01605786 ↗ |
| Known as | PfPEBS-LSP | “PfPEBS-LSP, is a synthetic polypeptide corresponding to amino acids 3112 to 3244 (131aa) from the Pf 11.1 antigen in 3D7 parasite sequence.” NCT01605786 ↗ |
| Modality | Vaccine | “Malaria Vaccine Candidate, PfPEBS” NCT01605786 ↗ |